Abeona Therapeutics
在场
Abeona Therapeutics 是一家在股票代码 ABEO (US) 下上市的公司。
高管
查看带有其 19 名主要高管的组织结构图
Abeona Therapeutics 搜索最多的简介
- Vishwas Seshadri, Chief Executive Officer and Director
- Michael Amoroso, Chairman of the Board
- Christine Silverstein, Director
高管在Abeona Therapeutics变化
- Bernhardt Zeiher已作为Director加入公司 (新闻发布的2024八月15号).
创建提醒
跟踪 Abeona Therapeutics 的高管变动
药店
Abeona Therapeutics 拥有 1,829 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Johnson & Johnson (美国(美洲))。
Popular M&A news in 药店
- Revance Therapeutics has announced the acquisition of Revance Therapeutics (公布2025一月14号).
- Stemtech and Seacret Direct have announced they will merge (公布2024十二月5号)..
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
药店 行业的其他推荐联系人
消息
Abeona Therapeutics 的最新新闻稿
- Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Press Releases
- Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
- Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa
- Abeona Therapeutics® Announces Participation in November Investor Conferences
- Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration
- Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
- View more press releases Close
通过电子邮件
